BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3052541)

  • 1. [Cell kinetics of oligodendroglioma and oligo-astrocytoma--Ki-67 PaP study].
    Shibata T; Burger PC; Kleihues P
    No To Shinkei; 1988 Aug; 40(8):779-85. PubMed ID: 3052541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
    Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
    Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [KI-67 PAP stain for histologic grading of brain tumors by squash preparations].
    Shibata T; Ostertag CB; Volk B
    No To Shinkei; 1989 Jan; 41(1):55-60. PubMed ID: 2470401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of malignant features in oligodendroglial tumors.
    Saito A; Nakazato Y
    Clin Neuropathol; 1999; 18(2):61-73. PubMed ID: 10192700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
    Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
    J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
    Perry A; Aldape KD; George DH; Burger PC
    Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cell kinetics of human meningiomas and neurinomas--Ki-67 PAP stain].
    Shibata T; Burger PC; Kleihues P
    No Shinkei Geka; 1988 Jul; 16(8):939-44. PubMed ID: 3050583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
    Majumdar K; Radotra BD; Vasishta RK; Pathak A
    Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous growth of mean tumor diameter in a subset of grade II gliomas.
    Mandonnet E; Delattre JY; Tanguy ML; Swanson KR; Carpentier AF; Duffau H; Cornu P; Van Effenterre R; Alvord EC; Capelle L
    Ann Neurol; 2003 Apr; 53(4):524-8. PubMed ID: 12666121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?
    Muragaki Y; Chernov M; Maruyama T; Ochiai T; Taira T; Kubo O; Nakamura R; Iseki H; Hori T; Takakura K
    Minim Invasive Neurosurg; 2008 Oct; 51(5):275-9. PubMed ID: 18855292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
    Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
    Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitosis identification in diffuse gliomas: implications for tumor grading.
    Coons SW; Pearl DK
    Cancer; 1998 Apr; 82(8):1550-5. PubMed ID: 9554533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histological classification of human gliomas: state of art and controversies].
    Figarella-Branger D; Bouvier C
    Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytologic diagnosis of glial tumors of the central nervous system].
    Shakunov AN; Triputin ES
    Arkh Patol; 1987; 49(1):41-6. PubMed ID: 3827633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of apoptotic cells in archival tissue from diffuse astrocytomas using a monoclonal antibody to single-stranded DNA.
    Korkolopoulou PA; Konstantinidou AE; Patsouris ES; Christodoulou PN; Thomas-Tsagli EA; Davaris PS
    J Pathol; 2001 Mar; 193(3):377-82. PubMed ID: 11241419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.